BCL-2-family protein tBID can act as a BAX-like effector of apoptosis.


Journal

The EMBO journal
ISSN: 1460-2075
Titre abrégé: EMBO J
Pays: England
ID NLM: 8208664

Informations de publication

Date de publication:
17 12 2022
Historique:
revised: 14 11 2021
received: 10 05 2021
accepted: 22 11 2021
pubmed: 22 12 2021
medline: 17 2 2022
entrez: 21 12 2021
Statut: ppublish

Résumé

During apoptosis, the BCL-2-family protein tBID promotes mitochondrial permeabilization by activating BAX and BAK and by blocking anti-apoptotic BCL-2 members. Here, we report that tBID can also mediate mitochondrial permeabilization by itself, resulting in release of cytochrome c and mitochondrial DNA, caspase activation and apoptosis even in absence of BAX and BAK. This previously unrecognized activity of tBID depends on helix 6, homologous to the pore-forming regions of BAX and BAK, and can be blocked by pro-survival BCL-2 proteins. Importantly, tBID-mediated mitochondrial permeabilization independent of BAX and BAK is physiologically relevant for SMAC release in the immune response against Shigella infection. Furthermore, it can be exploited to kill leukaemia cells with acquired venetoclax resistance due to lack of active BAX and BAK. Our findings define tBID as an effector of mitochondrial permeabilization in apoptosis and provide a new paradigm for BCL-2 proteins, with implications for anti-bacterial immunity and cancer therapy.

Identifiants

pubmed: 34931711
doi: 10.15252/embj.2021108690
pmc: PMC8762556
doi:

Substances chimiques

Apoptosis Regulatory Proteins 0
BAK1 protein, human 0
BCL2 protein, human 0
BH3 Interacting Domain Death Agonist Protein 0
DIABLO protein, human 0
Mitochondrial Proteins 0
Proto-Oncogene Proteins c-bcl-2 0
bcl-2 Homologous Antagonist-Killer Protein 0
bcl-2-Associated X Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e108690

Informations de copyright

© 2021 The Authors Published under the terms of the CC BY 4.0 license.

Références

EMBO J. 2020 Dec 1;39(23):e105753
pubmed: 33124082
J Exp Med. 2003 Jul 21;198(2):341-7
pubmed: 12874265
J Biol Chem. 2001 Aug 17;276(33):31083-91
pubmed: 11399768
Nat Struct Mol Biol. 2009 Nov;16(11):1178-85
pubmed: 19820711
Eur J Biochem. 2001 Jan;268(1):48-55
pubmed: 11121101
Pharmacol Res. 2021 Jan;163:105297
pubmed: 33181319
Cell. 2013 Jan 31;152(3):519-31
pubmed: 23374347
Oncogene. 2008 Dec;27 Suppl 1:S93-104
pubmed: 19641510
EMBO J. 2018 Sep 3;37(17):
pubmed: 30049712
Life Sci Alliance. 2020 Apr 28;3(6):
pubmed: 32345661
EMBO J. 2016 Feb 15;35(4):402-13
pubmed: 26783364
Science. 2018 Feb 23;359(6378):
pubmed: 29472455
J Biol Chem. 2003 Dec 5;278(49):48935-41
pubmed: 14522999
Cell. 1999 Mar 5;96(5):615-24
pubmed: 10089877
J Biol Chem. 2020 Feb 7;295(6):1623-1636
pubmed: 31901077
J Immunol. 2011 Apr 1;186(7):4059-66
pubmed: 21339359
Cell. 1996 Jul 12;86(1):147-57
pubmed: 8689682
Cell. 1998 Aug 21;94(4):481-90
pubmed: 9727491
Science. 1997 Dec 12;278(5345):1966-8
pubmed: 9395403
Biochemistry. 2004 Aug 31;43(34):10930-43
pubmed: 15323553
Proc Natl Acad Sci U S A. 1999 May 11;96(10):5492-7
pubmed: 10318911
J Exp Med. 1995 Aug 1;182(2):367-77
pubmed: 7629499
Cell Death Differ. 2019 Oct;26(10):1880-1894
pubmed: 30560933
Nat Methods. 2019 Aug;16(8):711-714
pubmed: 31263253
Cell Death Differ. 2018 Jan;25(1):65-80
pubmed: 29149100
Sci Rep. 2017 Nov 24;7(1):16259
pubmed: 29176554
Biochim Biophys Acta. 2004 Mar 1;1644(2-3):83-94
pubmed: 14996493
Mol Cell Biol. 2001 Nov;21(21):7268-76
pubmed: 11585909
Biophys J. 2010 Nov 3;99(9):2917-25
pubmed: 21044589
Biochim Biophys Acta. 2016 Mar;1858(3):457-466
pubmed: 26375417
J Cell Biol. 2011 Jul 11;194(1):39-48
pubmed: 21727192
ACS Chem Biol. 2014 Dec 19;9(12):2852-63
pubmed: 25314294
J Membr Biol. 2015 Jun;248(3):545-61
pubmed: 26087906
Adv Cancer Res. 2018;137:37-75
pubmed: 29405977
N Engl J Med. 2019 Jun 06;380(23):2225-2236
pubmed: 31166681
J Biol Chem. 1999 Jan 8;274(2):1156-63
pubmed: 9873064
Cereb Cortex. 2020 Mar 21;30(2):505-524
pubmed: 31240311
PLoS One. 2012;7(4):e35910
pubmed: 22540011
Nat Cell Biol. 2006 Dec;8(12):1348-58
pubmed: 17115033
J Biol Chem. 2004 Jul 16;279(29):30081-91
pubmed: 15138279
FEBS J. 2009 Nov;276(21):6338-54
pubmed: 19796174
FEBS J. 2017 Mar;284(5):711-724
pubmed: 28064468
Nano Lett. 2019 Oct 9;19(10):6937-6944
pubmed: 31558028
Cell. 2016 Apr 7;165(2):421-33
pubmed: 26949185
Mol Cell. 2008 May 9;30(3):369-80
pubmed: 18471982
Cell Death Dis. 2020 Apr 23;11(4):268
pubmed: 32327636
Biophys J. 2005 Jun;88(6):3976-90
pubmed: 15778450
Genes Dev. 2016 Apr 15;30(8):973-88
pubmed: 27056669
J Biol Chem. 2000 Jul 28;275(30):22713-8
pubmed: 10801880
Biomolecules. 2020 Dec 04;10(12):
pubmed: 33291826
Cell Death Differ. 2007 Mar;14(3):447-52
pubmed: 16946732
Cold Spring Harb Perspect Biol. 2020 Apr 1;12(4):
pubmed: 31570337
Cell. 2000 Nov 10;103(4):645-54
pubmed: 11106734
Cells. 2020 Feb 11;9(2):
pubmed: 32053868
Methods. 2017 May 15;121-122:29-44
pubmed: 28522326
Nat Commun. 2017 Jul 13;8(1):73
pubmed: 28706229
EMBO J. 2016 Feb 15;35(4):389-401
pubmed: 26783362
Cell Death Dis. 2013 Jun 20;4:e683
pubmed: 23788040
Sci Rep. 2012;2:257
pubmed: 22355769
Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):17975-80
pubmed: 16330765
Cold Spring Harb Perspect Biol. 2013 Feb 01;5(2):
pubmed: 23378585
Nature. 1996 May 23;381(6580):335-41
pubmed: 8692274
Dev Cell. 2002 Jan;2(1):55-67
pubmed: 11782314
Front Cell Infect Microbiol. 2017 Nov 14;7:471
pubmed: 29184851
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18081-7
pubmed: 18981409
EMBO J. 2022 Jan 4;41(1):e107640
pubmed: 34779515
Nat Rev Mol Cell Biol. 2019 Mar;20(3):175-193
pubmed: 30655609
IUBMB Life. 2017 Jun;69(6):423-434
pubmed: 28276141
Nature. 2020 Apr;580(7804):542-547
pubmed: 32322059
Cell. 1999 Mar 5;96(5):625-34
pubmed: 10089878
Cell. 1998 Aug 21;94(4):491-501
pubmed: 9727492
J Immunol. 2000 Jul 15;165(2):903-14
pubmed: 10878365
EMBO J. 2016 Jan 18;35(2):208-36
pubmed: 26702098
Mol Cell. 2014 Sep 18;55(6):938-946
pubmed: 25175025
Cell Death Dis. 2020 Jul 27;11(7):590
pubmed: 32719312
EMBO J. 2014 Oct 1;33(19):2171-87
pubmed: 25056906

Auteurs

Hector Flores-Romero (H)

Institute for Genetics, University of Cologne, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
Interfaculty Institute of Biochemistry, Eberhard-Karls-Universität Tübingen, Tübingen, Germany.

Lisa Hohorst (L)

Institute for Genetics, University of Cologne, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Malina John (M)

Interfaculty Institute of Biochemistry, Eberhard-Karls-Universität Tübingen, Tübingen, Germany.

Marie-Christine Albert (MC)

Institute for Molecular Immunology, and Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine, University Hospital of Cologne, University of Cologne, Cologne, Germany.

Louise E King (LE)

Institute for Genetics, University of Cologne, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.

Laura Beckmann (L)

Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
Center of Integrated Oncology ABCD, University Hospital of Cologne, Cologne, Germany.

Tamas Szabo (T)

Division of Developmental Immunology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.

Vanessa Hertlein (V)

Interfaculty Institute of Biochemistry, Eberhard-Karls-Universität Tübingen, Tübingen, Germany.

Xu Luo (X)

Eppley Institute for Research in Cancer and Allied Diseases, Fred & Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, ME, USA.
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE, USA.

Andreas Villunger (A)

Division of Developmental Immunology, Biocenter, Medical University of Innsbruck, Innsbruck, Austria.
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna, Austria.

Lukas P Frenzel (LP)

Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
Department I of Internal Medicine, University Hospital of Cologne, Cologne, Germany.
Center of Integrated Oncology ABCD, University Hospital of Cologne, Cologne, Germany.

Hamid Kashkar (H)

Institute for Molecular Immunology, and Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine, University Hospital of Cologne, University of Cologne, Cologne, Germany.

Ana J Garcia-Saez (AJ)

Institute for Genetics, University of Cologne, Cologne, Germany.
Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany.
Interfaculty Institute of Biochemistry, Eberhard-Karls-Universität Tübingen, Tübingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH